Quince Therapeutics Resolves EIB Debt Obligations, Advances Restructuring Plans

lunes, 30 de marzo de 2026, 8:31 am ET1 min de lectura
QNCX--

Quince Therapeutics has settled its outstanding debt obligations with the European Investment Bank for $16.4 million, with a $5.5 million payment marking a significant milestone in the company's restructuring efforts. The settlement resolves critical debt obligations and allows Quince to advance its strategic alternatives aimed at maximizing shareholder value. The company is currently evaluating strategic alternatives, including mergers, asset sales, and other transactions.

Quince Therapeutics Resolves EIB Debt Obligations, Advances Restructuring Plans

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios